Engineering probiotics for therapeutic applications: recent examples and translational outlook
Current Opinion in Biotechnology
Saved in:
Main Authors: | NIKHIL AGGARWAL, Breedon, AME, Davis, CM, Hwang In Young, Chang,Matthew Wook |
---|---|
Other Authors: | BIOCHEMISTRY |
Format: | Review |
Published: |
Elsevier BV
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/170022 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Phage-boosted chemotherapy
by: NIKHIL AGGARWAL, et al.
Published: (2020) -
Designer probiotics for the prevention and treatment of human diseases
by: Chua, Koon Jiew, et al.
Published: (2023) -
Engineering commensal bacteria to rewire host–microbiome interactions
by: Hwang In Young, et al.
Published: (2020) -
An engineered probiotic produces a type III interferon IFNL1 and reduces inflammations in in vitro inflammatory bowel disease models
by: Chua, Koon Jiew, et al.
Published: (2023) -
An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
by: Chua, Koon Jiew, et al.
Published: (2023)